Phenotype and imaging features associated with APP duplications.
APP duplication
Alzheimer disease
Autosomal dominant
Cerebral MRI
Cerebral amyloid angiopathy
Journal
Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643
Informations de publication
Date de publication:
11 05 2023
11 05 2023
Historique:
received:
19
08
2022
accepted:
18
01
2023
medline:
15
5
2023
pubmed:
12
5
2023
entrez:
11
5
2023
Statut:
epublish
Résumé
APP duplication is a rare genetic cause of Alzheimer disease and cerebral amyloid angiopathy (CAA). We aimed to evaluate the phenotypes of APP duplications carriers. Clinical, radiological, and neuropathological features of 43 APP duplication carriers from 24 French families were retrospectively analyzed, and MRI features and cerebrospinal fluid (CSF) biomarkers were compared to 40 APP-negative CAA controls. Major neurocognitive disorders were found in 90.2% symptomatic APP duplication carriers, with prominent behavioral impairment in 9.7%. Symptomatic intracerebral hemorrhages were reported in 29.2% and seizures in 51.2%. CSF Aβ42 levels were abnormal in 18/19 patients and 14/19 patients fulfilled MRI radiological criteria for CAA, while only 5 displayed no hemorrhagic features. We found no correlation between CAA radiological signs and duplication size. Compared to CAA controls, APP duplication carriers showed less disseminated cortical superficial siderosis (0% vs 37.5%, p = 0.004 adjusted for the delay between symptoms onset and MRI). Deep microbleeds were found in two APP duplication carriers. In addition to neurofibrillary tangles and senile plaques, CAA was diffuse and severe with thickening of leptomeningeal vessels in all 9 autopsies. Lewy bodies were found in substantia nigra, locus coeruleus, and cortical structures of 2/9 patients, and one presented vascular amyloid deposits in basal ganglia. Phenotypes associated with APP duplications were heterogeneous with different clinical presentations including dementia, hemorrhage, and seizure and different radiological presentations, even within families. No apparent correlation with duplication size was found. Amyloid burden was severe and widely extended to cerebral vessels as suggested by hemorrhagic features on MRI and neuropathological data, making APP duplication an interesting model of CAA.
Sections du résumé
BACKGROUND
APP duplication is a rare genetic cause of Alzheimer disease and cerebral amyloid angiopathy (CAA). We aimed to evaluate the phenotypes of APP duplications carriers.
METHODS
Clinical, radiological, and neuropathological features of 43 APP duplication carriers from 24 French families were retrospectively analyzed, and MRI features and cerebrospinal fluid (CSF) biomarkers were compared to 40 APP-negative CAA controls.
RESULTS
Major neurocognitive disorders were found in 90.2% symptomatic APP duplication carriers, with prominent behavioral impairment in 9.7%. Symptomatic intracerebral hemorrhages were reported in 29.2% and seizures in 51.2%. CSF Aβ42 levels were abnormal in 18/19 patients and 14/19 patients fulfilled MRI radiological criteria for CAA, while only 5 displayed no hemorrhagic features. We found no correlation between CAA radiological signs and duplication size. Compared to CAA controls, APP duplication carriers showed less disseminated cortical superficial siderosis (0% vs 37.5%, p = 0.004 adjusted for the delay between symptoms onset and MRI). Deep microbleeds were found in two APP duplication carriers. In addition to neurofibrillary tangles and senile plaques, CAA was diffuse and severe with thickening of leptomeningeal vessels in all 9 autopsies. Lewy bodies were found in substantia nigra, locus coeruleus, and cortical structures of 2/9 patients, and one presented vascular amyloid deposits in basal ganglia.
DISCUSSION
Phenotypes associated with APP duplications were heterogeneous with different clinical presentations including dementia, hemorrhage, and seizure and different radiological presentations, even within families. No apparent correlation with duplication size was found. Amyloid burden was severe and widely extended to cerebral vessels as suggested by hemorrhagic features on MRI and neuropathological data, making APP duplication an interesting model of CAA.
Identifiants
pubmed: 37170141
doi: 10.1186/s13195-023-01172-2
pii: 10.1186/s13195-023-01172-2
pmc: PMC10173644
doi:
Substances chimiques
Amyloid
0
APP protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
93Informations de copyright
© 2023. The Author(s).
Références
Stroke. 2014 Oct;45(10):2930-5
pubmed: 25116879
JAMA Neurol. 2021 Sep 1;78(9):1080-1090
pubmed: 34279544
J Alzheimers Dis. 2019;71(1):227-243
pubmed: 31381512
Neurology. 2019 Jul 23;93(4):e358-e371
pubmed: 31243071
Neurology. 2017 Nov 21;89(21):2128-2135
pubmed: 29070669
PLoS Med. 2017 Mar 28;14(3):e1002270
pubmed: 28350801
Lancet. 2020 Jun 27;395(10242):1988-1997
pubmed: 32593336
J Alzheimers Dis. 2022;87(2):791-802
pubmed: 35367960
Neurology. 2016 Aug 30;87(9):912-9
pubmed: 27466472
Clin Chem. 2019 Sep;65(9):1153-1160
pubmed: 31292136
Nat Genet. 2006 Jan;38(1):24-6
pubmed: 16369530
J Alzheimers Dis. 2015;44(1):103-14
pubmed: 25182745
Radiology. 2018 Apr;287(1):11-28
pubmed: 29558307
Neurology. 2002 Jun 25;58(12):1791-800
pubmed: 12084879
Neurol Genet. 2021 Sep 08;7(5):e609
pubmed: 34532568
J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):967-72
pubmed: 1431963
J Alzheimers Dis. 2013;37(4):789-93
pubmed: 23948920
Stroke. 2018 Feb;49(2):491-497
pubmed: 29335334
Neurology. 2008 Dec 2;71(23):1925-6
pubmed: 19047566
Stroke. 2018 Aug;49(8):1913-1919
pubmed: 30012821
Mol Psychiatry. 2015 Sep;20(9):1046-56
pubmed: 26194182
J Alzheimers Dis. 2017;56(1):37-46
pubmed: 27858710
F1000Res. 2016 May 12;5:
pubmed: 27239286
J Alzheimers Dis. 2012;28(3):561-6
pubmed: 22045488
Neurology. 2020 Dec 15;95(24):e3331-e3343
pubmed: 32913026
Neurology. 2010 Apr 27;74(17):1346-50
pubmed: 20421578
Brain. 2006 Nov;129(Pt 11):2966-76
pubmed: 16959815
J Alzheimers Dis. 2012;30(4):847-56
pubmed: 22475797
Nat Neurosci. 2010 Jul;13(7):812-8
pubmed: 20581818
Brain. 2006 Nov;129(Pt 11):2977-83
pubmed: 16921174
PLoS Med. 2021 Sep 23;18(9):e1003801
pubmed: 34555025
J Neural Transm (Vienna). 2009 Feb;116(2):203-12
pubmed: 19142572
Alzheimers Dement. 2016 Jun;12(6):733-48
pubmed: 27016693
Nat Rev Neurol. 2020 Jan;16(1):30-42
pubmed: 31827267
Stroke. 2018 Jun;49(6):1518-1520
pubmed: 29695466
Mol Psychiatry. 2021 Oct;26(10):5766-5788
pubmed: 32647257
Acta Neuropathol. 2018 Oct;136(4):569-587
pubmed: 29770843
Neurology. 2014 Nov 11;83(20):1838-43
pubmed: 25320098
J Neurol Neurosurg Psychiatry. 2009 Sep;80(9):1050-2
pubmed: 19684239
Alzheimers Res Ther. 2014 Jun 26;6(3):38
pubmed: 25478015
J Neurol Neurosurg Psychiatry. 2021 Feb 9;:
pubmed: 33563804
Rev Neurosci. 2014;25(5):641-51
pubmed: 24870607
Cerebrovasc Dis. 2002;13 Suppl 2:31-6
pubmed: 11901240
Acta Neuropathol. 2019 Feb;137(2):183-207
pubmed: 30478624
J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):901-8
pubmed: 23457231
Brain. 2015 Aug;138(Pt 8):2126-39
pubmed: 26115675